Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PTCT -20.7%, ENPH -19.3%, SNY -17.6% (cut FY24 outlook; will split consumer and pharm businesses), NWL -12%, NWG -11% (also provides key findings from Phase 1 of Travers Smith review), BIO -7.4%, GTLS -6.6%, CRI -5.8%, SBCF -5.7%, OLN -5.5%, ELME -4.6% (also authorizes new $50 mln share repurchase program), EXPO -4.6%, AON -4.6%, HUBG -4.3% (also 2-for-1 split; initiates dividend; new $250 mln share repurchase plan), CC -4.1%, BJRI -4.1%, LYB -4%, CHTR -3.8%, F -3.3%, PEB -3.2%, COLM -3%, XEL -2.5%, AX -2.2%, ESS -2.2%, CVX -2.2%, CBRE -2.2%, TEX -2.1%, B -2.1%, LECO -2.1%, SAM -1.9%, NOV -1.5% (also to consolidate operating structure), ROG -1.2%, BAH -1.1%, FTS -1%
Other news:
- MCBC -2% (increases dividend)
- CSTR -1.9% (ONB to acquire CSTR)
- ONB -1% (ONB to acquire CSTR)
Analyst comments:
- ULCC -1.9% (downgraded to Hold from Buy at Deutsche Bank)
- LUV -1.5% (downgraded to Market Perform from Outperform at TD Cowen)